iBio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

iBio (NASDAQ: IBIO) announced executive participation in two investor conferences: a virtual fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 26, 2026 at 2:00 p.m. ET, and a fireside chat at the Leerink Global Healthcare Conference on Monday, March 9, 2026 at 4:20 p.m. ET in Miami.

Martin Brenner, DVM, Ph.D., CEO and CSO, and Felipe Duran, CFO, will present and be available for one-on-one meetings; livestreams and replays will be accessible via the investor site for 90 days.

News Market Reaction – IBIO

+0.82%

12 alerts

+0.82% News Effect

+6.1% Peak in 11 min

+$760K Valuation Impact

$93M Market Cap

0.3x Rel. Volume

On the day this news was published, IBIO gained 0.82%, reflecting a mild positive market reaction. Argus tracked a peak move of +6.1% during that session. Our momentum scanner triggered 12 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $760K to the company's valuation, bringing the market cap to $93M at that time.

Data tracked by StockTitan Argus on the day of publication.

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in fireside chats at the Oppenheimer 36^th Annual Healthcare Life Sciences Conference and the Leerink Global Healthcare Conference.

Oppenheimer 36^th Annual Healthcare Life Sciences Conference
Presentation Date: Thursday, February 26, 2026
Time: 2:00 p.m. ET
Location: Virtual
A livestream of the event can be accessed here.

Leerink Global Healthcare Conference
Presentation Date: Monday, March 9, 2026
Time: 4:20 p.m. ET
Location: Miami, FL
A livestream of the event can be accessed here.

Dr. Brenner and Mr. Duran will be available for one-on-one meetings during both conferences.

A link to access each of the replays will be available on the Investor section of the iBio website for 90 days after the event.

About iBio, Inc.

iBio (Nasdaq: IBIO) is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling with innovative drug discovery platforms, iBio is creating a pipeline of breakthrough antibody treatments to address significant unmet medical needs. iBio’s mission is to transform drug discovery, accelerate development timelines, and unlock new possibilities in precision medicine. For more information, visit www.ibioinc.com or follow us on LinkedIn.

Corporate Contact:
iBio, Inc.
Investor Relations
ir@ibioinc.com

Media Contacts:
Ignacio Guerrero-Ros, Ph.D., or David Schull
Russo Partners, LLC
Ignacio.guerrero-ros@russopartnersllc.com
David.schull@russopartnersllc.com
(858) 717-2310 or (646) 942-5604

FAQ

When will iBio (IBIO) present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference?

iBio will present on Thursday, February 26, 2026 at 2:00 p.m. ET via a virtual fireside chat. According to iBio, Martin Brenner and Felipe Duran will participate and a livestream is available, with replay access on the investor site for 90 days.

When and where is iBio (IBIO) scheduled to speak at the Leerink Global Healthcare Conference?

iBio is scheduled to speak Monday, March 9, 2026 at 4:20 p.m. ET in Miami, FLA as a fireside chat. According to iBio, the session will be livestreamed and replays will be posted on the investor section for 90 days.

How can investors watch iBio (IBIO) presentations and access replays?

Investors can watch via livestreams and access replays on iBio's investor website for 90 days after each event. According to iBio, replay links will be posted on the investor section and livestreams are available for both conferences.

Who will represent iBio (IBIO) at the Oppenheimer and Leerink conferences?

Martin Brenner, CEO and Chief Scientific Officer, and Felipe Duran, CFO, will represent iBio in fireside chats and meetings. According to iBio, both executives will participate and be available for one-on-one meetings at each conference.

Will iBio (IBIO) executives be available for one-on-one investor meetings at the conferences?

Yes; iBio executives will be available for one-on-one meetings during both conferences. According to iBio, Martin Brenner and Felipe Duran will meet with investors at Oppenheimer and Leerink in addition to their fireside sessions.

How long will iBio (IBIO) replay recordings remain available after the events?

Replays will remain available on iBio's investor site for 90 days after each event. According to iBio, links to access each replay will be posted on the investor section and accessible for that 90-day window.